PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

USPTO PatentsView assignee record - 20 granted patents across 6 technology areas, recorded in grant years 2018–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Shanghai ranks #14,926 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 6 technology areas.

#14,926
of 49,997 US assignees by volume
21st percentile
by Innovation Score (26.6/100)
12.3
avg claims per patent
+133%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14926 · Foreign Corporation #14,926 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 20 grants
  • MID-PACK #14,926/49,997
  • PHOTO-FINISH Sega Sammy Creation
  • CPC-NARROW A61P · 6 areas
  • INNOV-THIN 26.6/100
  • CLAIMS-RICH 12.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +133% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sega Sammy Creation Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Shanghai’s 26.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Shanghai

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Shanghai's Innovation Score is 26.6/100 (21st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Shanghai?

Each dot is one of Shanghai’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Shanghai’s own 12.3 claims/patent is at or below the 13.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Shanghai vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 19.919.92020.1 0510152025 Granted patents (volume) Avg claims / patent Sega Sammy Creation Inc. - 20, 7.95Sega Sammy Creati…Selex ES S.P.A. - 20, 13.7Selex ES S P ASemitec Corporation - 20, 13.2SemitecShake-n-go Fashion, Inc. - 20, 13.2Shake-n-go FashionShanghai Jinko Green Energy Enterprise Management Co., Ltd. - 20, 15.75Shanghai Jinko Gr…Shanghai Sensetime Intelligent Technology Co., Ltd - 20, 20.4Shanghai Sensetim…Shanghai Tianxun Electronic Equipment Co., Ltd - 20, 1Shanghai Tianxun…Shanghai Xiaoi Robot Technology Co., Ltd. - 20, 18.2Shanghai Xiaoi Ro…Shanghai Haiyan Pharmaceutical Technology Co., Ltd. - 20, 12.3Shanghai Haiyan P…
Shanghai vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Shanghai's grants concentrate

Shanghai Haiyan Pharmaceutical Technology Co., Ltd. is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (7 grants) versus a trough of 2 in 2019. By volume, Shanghai sits between Sega Sammy Creation Inc. and Shanghai Xiaoi Robot Technology Co., Ltd..

Who files at Shanghai's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Shanghai holds 20 patents at rank #14,917, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Shanghai

By rank, the assignees closest to #14,917 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Shanghai's primary technology class.

Shanghai's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 21st percentile higher than 21% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 2018201920202021 7
USPTO utility patent grants by year · 2018–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 4 20.0%
2019 2 10.0%
2020 7 35.0%
2021 7 35.0%

Which technologies does Shanghai Haiyan Pharmaceutical Technology Co., Ltd. patent most?

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.'s patent record in context - here's where to go next.

  • Shanghai Haiyan Pharmaceutical Technology Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #14,926 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Shanghai Haiyan Pharmaceutical Technology Co., Ltd. against Sega Sammy Creation Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 26.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.